- Home
- APLT vs AMSF Comparison
APLT vs AMSF Comparison
Compare APLT & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AMSF
- Stock Information
- Founded
- APLT 2016
- AMSF 1985
- Country
- APLT United States
- AMSF United States
- Employees
- APLT N/A
- AMSF N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AMSF Accident &Health Insurance
- Sector
- APLT Health Care
- AMSF Finance
- Exchange
- APLT Nasdaq
- AMSF Nasdaq
- Market Cap
- APLT 52.9M
- AMSF 869.6M
- IPO Year
- APLT 2019
- AMSF 2005
- Fundamental
- Price
- APLT $0.33
- AMSF $43.79
- Analyst Decision
- APLT Buy
- AMSF Buy
- Analyst Count
- APLT 7
- AMSF 2
- Target Price
- APLT $6.10
- AMSF $59.50
- AVG Volume (30 Days)
- APLT 2.3M
- AMSF 159.1K
- Earning Date
- APLT 08-06-2025
- AMSF 07-24-2025
- Dividend Yield
- APLT N/A
- AMSF 10.41%
- EPS Growth
- APLT N/A
- AMSF N/A
- EPS
- APLT N/A
- AMSF 2.48
- Revenue
- APLT $265,000.00
- AMSF $301,216,000.00
- Revenue This Year
- APLT $1,768.13
- AMSF $1.69
- Revenue Next Year
- APLT $292.85
- AMSF $6.54
- P/E Ratio
- APLT N/A
- AMSF $17.66
- Revenue Growth
- APLT N/A
- AMSF N/A
- 52 Week Low
- APLT $0.30
- AMSF $42.48
- 52 Week High
- APLT $10.62
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- APLT 46.71
- AMSF 36.62
- Support Level
- APLT $0.30
- AMSF $42.48
- Resistance Level
- APLT $0.36
- AMSF $44.27
- Average True Range (ATR)
- APLT 0.03
- AMSF 0.82
- MACD
- APLT 0.00
- AMSF 0.02
- Stochastic Oscillator
- APLT 46.22
- AMSF 32.52
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums.